Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy

AIDS

Volumn 17, Issue 13, 2003, Pages 1917-1923

  Bruera, Dario ^a,c   Luna, Norma ^b   David, Daniel O ^b   Bergoglio, Liliana M ^a   Zamudio, Javier ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Hospital Rawson   (Argentina)

^c NONE   (Argentina)

Author keywords

AIDS; Bone mineral density; HIV infection; Osteopenia; Osteoporosis

Indexed keywords

ANTIRETROVIRUS AGENT; CALCIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; PYRIDINOLINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; BONE MINERAL; CALCIUM URINE LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; SEROCONVERSION; T LYMPHOCYTE ACTIVATION;

ADULT; ANTHROPOMETRY; ANTI-HIV AGENTS; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; HIV INFECTIONS; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; TIME FACTORS;

EID: 0041828172     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200309050-00010     Document Type: Article

References (27)

1. Paton NI, Macallan DC, Griffin GE, Pazianas M. Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int 1997, 61:30-32.
2. Teichmann J, Stephan E, Discher T, Lange U, Federlin K, Strake H, et al. Changes in calcitropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection. Metabolism 2000, 49:1134-1139.
3. Tebas P, Yarasheski M, Claxton S. Serum and urine markers of bone mineral metabolism in HIV-infected patients taking protease inhibitor-containing potent antiretroviral therapy. Antiviral Ther 2000, 5(Suppl 5):18 [abstract 029].
4. Aukrust P, Haug CJ, Ueland T, Lien E, Muller F, Espevik T, et al. Decreased bone formative and enhanced resortive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab 1999, 84:145-152.
5. Nolan D, Upton R, McKinnon E. Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 2001, 15:1275-1280.
6. Huang JS, Rietschel P, Hadigan CM. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS 2001, 15:975-982.
7. Carr A, Miller J, Eisman J, Cooper D. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 2001, 15:703-709.
8. Abu-Amer Y, Tondravi MM. NF - [Kappa] B and bone: the breaking point. Nat Med 1997, 3:189-190.
9. Levy JA. Pathogenesis of HIV infection. Microbiol Rev 1993, 57:163-289.
10. Buck BE, Resnick L, Shah SM, Malinin T. HIV cultured from bone: Implication for transplantation. Clin Orthop 1990, 251:249-253.
11. Huang CJ, Muller F, Aukrust P, Froland SS. Subnormal serum concentration of 1.25 dihydroxyvitamin D3 in HIV infection: correlation with degree of immunodeficiency and survival. J Infect Dis 1994, 169:889-893.
12. Huang CJ, Muller F, Aukrust P, Froland SS, Lien E. Disseminated Mycobacterium aviumcomplex in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. J Infect Dis 1996, 173:259-262.
13. Haug CJ, Aukrust P, Haug E, Morkrid L, Muller F, Froland SS, et al. Severe deficiency of 1.25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998, 83:3832-3838.
14. 2-vitamin D. Antiviral Ther 2000, 5(Suppl 5):19 [abstract 030].
15. Clerici M, Trabattoni D, Piconi S. A possible role for cortisol/anticortisol imbalance in the progression of HIV. Psychoneuroendocrinology 1997, 22:s27-s31.
16. Estephens EA, Das R, Madge S. Symptomatic osteoporosis in two young HIV-positive African women. AIDS 1999, 13:2605-2606.
17. Guaraldi G, Ventura P, Albuzza M. Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS 2001, 15:137-138.
18. Tebas P, Powderly WG, Claxton SH, Marin D, Tantisiriwat W, Teitelbaum S, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000, 14:3-67.
19. Moore AL, Vashisht A, Sabin C, Mocroft A, Madge S. Reduced bone mineral density in HIV-positive individuals. AIDS 2001, 15:1731-1733.
20. Nolan D, Upton R, McKinnon E. Longitudinal analysis of bone mineral density [DMO] in HIV-infected patients treated with HAART: change in subcutaneous fat; with an additional independent effect of indinavir therapy to increase DMO. Antiviral Ther 2000, 5(Suppl. 5):20.
21. Hoy J, Hudson J, Law M, Cooper DA. Osteopenia in a randomized multicenter study of protease inhibitor substitution in patients with the lipodystrophy syndrome and well - controlled HIV viremia. Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, January-February 2000 [abstract 59].
22. Hoy J, Hudson J, Cooper DA. Osteopenia in a randomized multicenter study of protease inhibitor substitution in patients with the lipodystrophy syndrome extended follow-up 48 weeks. Antiviral Ther 2000, 5(5uppl. 5):42. [abstract P32].
23. Moyle GJ, Newey C, Baldwin C, Torti C, Mandalia S. Osteopenia: a consequence of HIV not HAART? Antiviral Ther 2000, 5(Suppl. 5):43. [abstract P32].
24. Lawal A, Engelson ES, Wang J. Equivalent osteopenia in HIV. infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS 2001, 15:278-280.
25. Knobel H, Guelar A, Vallecillo G, Nogues X, Diez A. Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 2001, 15:807-808.
26. Carr A. Osteopenia in HIV infection. AIDS Clin Care 2001, 13:71-780.
27. World Health Organization. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical report series. Geneva: World Health Organization; 1994.